Estrella Immunopharma (ESLA) Short Interest Ratio & Short Volume → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free ESLA Stock Alerts $1.08 +0.05 (+4.85%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestSocial Media Estrella Immunopharma Short Interest DataCurrent Short Volume4,600 sharesPrevious Short Volume7,900 sharesChange Vs. Previous Month-41.77%Dollar Volume Sold Short$4,876.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares36,610,000 sharesFloat Size9,350,000 sharesShort Percent of Float0.05%Today's Trading Volume1,127 sharesAverage Trading Volume36,027 sharesToday's Volume Vs. Average3% Short Selling Estrella Immunopharma ? Sign up to receive the latest short interest report for Estrella Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatESLA Short Interest Over TimeESLA Days to Cover Over TimeESLA Percentage of Float Shorted Over Time Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Estrella Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,600 shares $4,876.00 -41.8%0.1%0.2 $1.06 3/31/20247,900 shares $9,796.00 +61.2%0.1%0.2 $1.24 3/15/20244,900 shares $5,439.00 -88.1%0.1%0.1 $1.11 2/29/202441,100 shares $41,922.00 -28.0%0.5%1 $1.02 2/15/202457,100 shares $62,239.00 +117.9%0.7%1.2 $1.09 1/31/202426,200 shares $29,344.00 No Change0.3%0.5 $1.12 ESLA Short Interest - Frequently Asked Questions What is Estrella Immunopharma's current short interest? Short interest is the volume of Estrella Immunopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,600 shares of ESLA short. 0.05% of Estrella Immunopharma's shares are currently sold short. Learn More on Estrella Immunopharma's current short interest. What is a good short interest percentage for Estrella Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of Estrella Immunopharma's floating shares are currently sold short. Is Estrella Immunopharma's short interest increasing or decreasing? Estrella Immunopharma saw a decline in short interest in April. As of April 15th, there was short interest totaling 4,600 shares, a decline of 41.8% from the previous total of 7,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Estrella Immunopharma's float size? Estrella Immunopharma currently has issued a total of 36,610,000 shares. Some of Estrella Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Estrella Immunopharma currently has a public float of 9,350,000 shares. How does Estrella Immunopharma's short interest compare to its competitors? 0.05% of Estrella Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Estrella Immunopharma: SAB Biotherapeutics, Inc. (0.34%), Dyadic International, Inc. (0.92%), Cyclo Therapeutics, Inc. (0.47%), Surrozen, Inc. (1.89%), MiNK Therapeutics, Inc. (0.49%), Protara Therapeutics, Inc. (4.35%), OKYO Pharma Limited (0.50%), IN8bio, Inc. (1.75%), Quince Therapeutics, Inc. (6.21%), Achilles Therapeutics plc (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Estrella Immunopharma stock? Short selling ESLA is an investing strategy that aims to generate trading profit from Estrella Immunopharma as its price is falling. ESLA shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estrella Immunopharma? A short squeeze for Estrella Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ESLA, which in turn drives the price of the stock up even further. How often is Estrella Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESLA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SAB Biotherapeutics Short Interest Data Dyadic International Short Interest Data Cyclo Therapeutics Short Interest Data Surrozen Short Interest Data MiNK Therapeutics Short Interest Data Protara Therapeutics Short Interest Data OKYO Pharma Short Interest Data IN8bio Short Interest Data Quince Therapeutics Short Interest Data Achilles Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ESLA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders